Seven cases of robot-assisted radical cystectomy with Bordeaux neobladder: A clinical observation

Background: Bladder cancer (BCa) poses a significant global health burden with mounting incidence and mortality rates. Effective treatment strategies are urgently needed to alleviate the disease burden and improve patients’ quality of life (QoL). Objective: This study aimed to evaluate the efficacy of robot-assisted radical cystectomy (RARC) plus the Bordeaux robotic intracorporeal orthotopic neobladder (riONB) technique for the treatment of BCa. Methods: We retrospectively analyzed clinical data from seven male patients who had undergone RARC with Bordeaux riONB between June 2023 and November 2024. The median age was 68 years, and the median body mass index was 24.2 kg/m2. The study assessed their demographic data, intra- and post-operative parameters, pathological characteristics, and complications. Results: The median operation time lasted for 583 min, with a median estimated blood loss of 375 mL and a median post-operative hospital stay of 10 days. Pathological results showed that five patients (71.4%) were at stage ≥T2. According to the Clavien-Dindo classification, six patients (85.7%) had grade I – II complications. At 6 months post-surgery, the average maximum cystometric capacity measured 397 mL, the average post-void residual urine volume was 29 mL, the average urine flow rate was 5.6 mL/s, and the incontinence-QoL score was 85. Daytime urinary control was good in five patients (71.4%), and nighttime control was good in three patients (42.9%). Conclusion: The results indicate that RARC + Bordeaux riONB is a safe and effective surgical option for BCa, accomplishing good patient recovery and significant clinical efficacy. However, the study was subject to limitations of a small sample size and a short follow-up period. Further research with larger cohorts and longer follow-up is warranted to confirm these findings.
- Jubber I, Ong S, Bukavina L, et al. Epidemiology of bladder cancer in 2023: A systematic review of risk factors. Eur Urol. 2023;84:176-190. doi: 10.1016/j.eururo.2023.03.029
- Zhang Y, Rumgay H, Li M, Yu H, Pan H, Ni J. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health. 2023;13:04109. doi: 10.7189/jogh.13.04109
- Zhang Y, Ding F, Han J, Wang Z, Tian W. Recent advances in innovative biomaterials for promoting bladder regeneration: Processing and functionalization. Front Bioeng Biotechnol. 2024;12:1528658. doi: 10.3389/fbioe.2024.1528658
- Bury MI, Fuller NJ, Wang X, et al. Multipotent bone marrow cell-seeded polymeric composites drive long-term, definitive urinary bladder tissue regeneration. PNAS Nexus. 2024;3:page038. doi: 10.1093/pnasnexus/pgae038
- Zhao L, Xia J, Yang C, et al. Poly(l-lactic acid)/gelatin microfiber membrane loaded with mitomycin C promoting bladder defect repair by anti-fibrosis and antibacterial action. J Mater Chem B. 2025;13:5427-5439. doi: 10.1039/d4tb02521k
- Goh AC, Gill IS, Lee DJ, et al. Robotic intracorporeal orthotopic ileal neobladder: Replicating open surgical principles. Eur Urol. 2012;62:891-901. doi: 10.1016/j.eururo.2012.07.052
- Kakizoe T. Orthotopic neobladder after cystectomy for bladder cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2020;96:255-265. doi: 10.2183/pjab.96.019
- Cormio A, D’Altilia N, Calo B, et al. Stapled w-shaped (hautmann) orthotopic ileal neobladder. Functional results and complications over a 13-year period. Eur Urol Focus. 2024;11:165-171. doi: 10.1016/j.euf.2024.09.002
- Pellegrino F, Scilipoti P, Rosiello G, et al. Long-term functional outcomes after robot-assisted radical cystectomy with intracorporeal ileal orthotopic neobladder. BJU Int. 2024;134:48-50. doi: 10.1111/bju.16337
- Tuderti G, Mastroianni R, Anceschi U, et al. Learning curve for intracorporeal robotic padua ileal bladder: 10-year functional assessment from a high-volume single-centre series. BJU Int. 2024;134:103-109. doi: 10.1111/bju.16328
- Lenis AT, Lec PM, Chamie K. Urinary diversion. JAMA. 2020;324:2222. doi: 10.1001/jama.2020.17604
- Nagele U, Anastasiadis AG, Stenzl A, Kuczyk M. Radical cystectomy with orthotopic neobladder for invasive bladder cancer: A critical analysis of long-term oncological, functional, and quality of life results. World J Urol. 2012;30:725-732. doi: 10.1007/s00345-011-0649-4
- Asimakopoulos AD, Campagna A, Gakis G, et al. Nerve sparing, robot-assisted radical cystectomy with intracorporeal bladder substitution in the male. J Urol. 2016;196:1549-1557. doi: 10.1016/j.juro.2016.04.114
- Asimakopoulos AD, Gubbiotti M, Agro EF, et al. “Bordeaux neobladder”: First evaluation of the urodynamic outcomes. Eur Urol Open Sci. 2023;47:102-109. doi: 10.1016/j.euros.2022.11.010
- Van Der Heijden AG, Bruins HM, Carrion A, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2025 guidelines. Eur Urol. 2025;87:582-600. doi: 10.1016/j.eururo.2025.02.019
- Wong CH, Ko IC, Kang SH, et al. Long-term outcomes of orthotopic neobladder versus ileal conduit urinary diversion in robot-assisted radical cystectomy (rarc): Multicenter results from the Asian rarc consortium. Ann Surg Oncol. 2024;31:5785-5793. doi: 10.1245/s10434-024-15396-5
- Bokarica P, Hrkac A, Gilja I. Re: J. Alfred witjes, thierry lebret, eva m. Comperat, et al. Updated 2016 eau guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71:462-75. Eur Urol. 2017;72:e45. doi: 10.1016/j.eururo.2017.02.031
- Khan A, Vuppalapati JK, Sarath LR, Mujeeburahiman M, D’Souza N. Functional outcome of robotic-assisted intracorporeal versus extracorporeal neobladder following radical cystectomy: Initial experience. Urol Ann. 2021;13:9-13. doi: 10.4103/UA.UA_132_19
- Fasanella D, Marchioni M, Domanico L, et al. Neobladder “function”: Tips and tricks for surgery and postoperative management. Life (Basel). 2022;12:1193. doi: 10.3390/life12081193
- Svatek RS, Fisher MB, Williams MB, et al. Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy. Urology. 2010;76:1419-1424. doi: 10.1016/j.urology.2010.02.053
- Ghodoussipour S, Ladi SS, Jiang D, et al. Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients. BJU Int. 2021;128:304-310. doi: 10.1111/bju.15329
- Ahmadi N, Clifford TG, Miranda G, et al. Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion. BJU Int. 2017;120:689-694. doi: 10.1111/bju.13916
- Akdemir E, Stuiver MM, Van De Kamp MW, et al. Long-term quality of life in patients with bladder cancer following radical cystectomy. BJU Int. 2024;135:675-683. doi: 10.1111/bju.16610
- Porreca A, Mineo BF, Romagnoli D, et al. Robot-assisted radical cystectomy with totally intracorporeal urinary diversion: Surgical and early functional outcomes through the learning curve in a single high-volume center. J Robot Surg. 2020;14:261-269. doi: 10.1007/s11701-019-00977-4
- Piramide F, Turri F, Amparore D, et al. Atlas of intracorporeal orthotopic neobladder techniques after robot-assisted radical cystectomy and systematic review of clinical outcomes. Eur Urol. 2024;85:348-360. doi: 10.1016/j.eururo.2023.11.017
- Satkunasivam R, Santomauro M, Chopra S, et al. Robotic intracorporeal orthotopic neobladder: Urodynamic outcomes, urinary function, and health-related quality of life. Eur Urol. 2016;69:247-253. doi: 10.1016/j.eururo.2015.06.041
- Grobet-Jeandin E, Benamran D, Pinar U, et al. Urodynamic assessment and quality of life outcomes of robot-assisted totally intracorporeal radical cystectomy and orthotopic neobladder for bladder cancer: A preliminary study. World J Urol. 2022;40:2535-2541. doi: 10.1007/s00345-022-04126-9
- Kato M, Takeda A, Saito S, et al. Long-term functional outcomes of ileal and sigmoid orthotopic neobladder procedures. Urology. 2007;69:74-77. doi: 10.1016/j.urology.2006.09.023
- Asimakopoulos AD, Finazzi AE, Piechaud T, Gakis G, Gaston R, Rosato E. Urodynamic parameters and continence outcomes in asymptomatic patients with ileal orthotopic neobladder: A systematic review and metanalysis. Cancers (Basel). 2024;16:1253. doi: 10.3390/cancers16071253
- Zhou X, Zheng J, He P, et al. Refinement surgical technique, and perioperative and functional outcomes in patients with robotic intracorporeal hautmann orthotopic neobladder. Urology. 2020;138:45-51. doi: 10.1016/j.urology.2020.01.025
- Keszthelyi A, Majoros A, Nyirady P, Mayer P, Bach D, Romics I. Voiding symptoms and urodynamic findings in patients with modified ileal neobladde. Pathol Oncol Res. 2009;15:307-313. doi: 10.1007/s12253-008-9099-8
- Martini A, Falagario UG, Russo A, et al. Robot-assisted radical cystectomy with orthotopic neobladder reconstruction: Techniques and functional outcomes in males. Eur Urol. 2023;84:484-490. doi: 10.1016/j.eururo.2023.04.009
- Bahlburg H, Schuster F, Tully KH, et al. Prospective evaluation of functional outcomes in 395 patients with an ileal neobladder 1 year after radical cystectomy. World J Urol. 2023;41:2367-2374. doi: 10.1007/s00345-023-04520-x
- Modh RA, Mulhall JP, Gilbert SM. Sexual dysfunction after cystectomy and urinary diversion. Nat Rev Urol. 2014;11:445-453. doi: 10.1038/nrurol.2014.151
- Chin WY, Choi EP, Wan EY, Chan AK, Chan KH, Lam CL. Evaluation of the outcomes of care of nurse-led continence care clinics for Chinese patients with lower urinary tract symptoms, a 2-year prospective longitudinal study. J Adv Nurs. 2017;73:1158-1171. doi: 10.1111/jan.13205
- Perimenis P, Koliopanou E. Postoperative management and rehabilitation of patients receiving an ileal orthotopic bladder substitution. Urol Nurs. 2004;24:383-386.